Opioid Switching from Morphine to Methadone Causes a Minor But Not Clinically Significant Increase in QTc Time: A Prospective 9-Month Follow-Up Study

Journal of Pain and Symptom Management

Volumn 32, Issue 2, 2006, Pages 180-185

  Fredheim, Olav Magnus S ^a   Borchgrevink, Petter C ^a   Hegrenæs, Lars ^a   Kaasa, Stein ^a   Dale, Ola ^a   Klepstad, Pål ^a  

^a Institute of Cancer Research and Molecular Biology   (Norway)

Author keywords

arrhythmia; chronic pain; Methadone; opioid switch; QT time

Indexed keywords

METHADONE; MORPHINE; OPIATE;

ADULT; AGED; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SUBSTITUTION; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART INDEX; HEART RIGHT BUNDLE BRANCH BLOCK; HIP OSTEOARTHRITIS; HUMAN; LOW BACK PAIN; MALE; NEUROPATHIC PAIN; PROSPECTIVE STUDY; QT PROLONGATION; QT TIME CORRECTED FOR HEART RATE; SHORT SURVEY; STATISTICAL SIGNIFICANCE; SUPRAVENTRICULAR TACHYCARDIA;

AGED; ANALGESICS, OPIOID; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; METHADONE; MIDDLE AGED; MORPHINE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 33746538531     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.02.010     Document Type: Short Survey

References (13)

1. Viskin S. Long QT syndromes and torsade de pointes. Lancet 354 (1999) 1625-1633
2. Kornick C.A., Kilborn M.J., Santiago-Palma J., et al. QTc interval prolongation associated with intravenous methadone. Pain 105 (2003) 499-506
3. Martell B.A., Ray B., and Gourevitch M.N. The impact of methadone induction on cardiac conduction in opiate users. Ann Intern Med 139 (2003) 154-155
4. Fredheim O., Kaasa S., Dale O., et al. Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study. Palliat Med 20 (2006) 35-41
5. Lawlor P., Turner K., Hanson J., and Bruera E. Dose ratio between morphine and methadone in patients with cancer pain. Cancer 82 (1998) 1167-1173
6. Ripamonti C., Groff L., Brunelli C., et al. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?. J Clin Oncol 16 (1998) 3216-3221
7. Krantz M.J., Lewkowiez L., Hays H., et al. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 137 (2002) 501-504
8. Maremmani I., Pacini M., Cesaroni C., et al. QTc interval prolongation in patients on long-term methadone maintenance therapy. Eur Addict Res 11 (2005) 44-49
9. Walker P.W., Klein D., and Kasza L. High dose methadone and ventricular arrhythmias: a report of three cases. Pain 103 (2003) 321-324
10. Gil M., Sala M., Anguers I., et al. QT prolongation and torsades de pointes in patients infected with human immunodeficiency virus and treated with methadone. Am J Cardiol 92 (2003) 995-997
11. Cruciani R.A., Sekine R., Homel P., et al. Measurement of QTc in patients receiving chronic methadone therapy. J Pain Symptom Manage 29 (2005) 385-391
12. Reddy S., Fisch M., and Bruera E. Oral methadone for cancer pain: no indication of QT interval prolongation or torsades de pointes. J Pain Symptom Manage 28 (2004) 301-303
13. Krantz M.J., Kutinsky I.B., Robertson A.D., and Mehler P.S. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy 23 (2003) 802-805